Ligand Pharmaceuticals LGND Balance Sheet (2010-2026)

NASDAQ LGND
$310.36 -3.74 (-1.19%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Ligand Pharmaceuticals Quarterly Balance Sheet

Periods 65 quarters
Latest Jun 2026

Ligand Pharmaceuticals reported total assets of $2185.88M and total liabilities of $1218.36M for the quarter ended Jun 2026, up 130.4% year over year. This balance sheet covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
23.43M19.52M14.99M5.28M4.12M45.01M88.73M28.45M19.27M22.95M50.09M18.14M63.62M72.31M47.99M67.67M139.38M174.93M115.08M1,006.70M
Short-term InvestmentsInvestments (Current)
299.78M321.59M189.01M142.66M117.29M166.86M193.94M190.60M171.23M147.35M260.50M208.79M156.02M183.86M160.91M177.35M525.15M558.59M664.33M351.06M
Cash & Current Investments
323.21M341.11M204.00M147.94M121.41M211.87M282.67M219.04M190.50M170.31M310.59M226.93M219.64M256.17M208.90M245.02M664.52M733.52M779.40M1,357.76M
Receivables - NetNet Receivables
64.34M85.45M41.80M62.31M65.17M30.42M29.19M27.99M36.00M32.92M28.43M37.48M34.32M38.38M38.49M41.29M57.56M59.60M53.38M67.01M
Receivables - OtherOther Receivables
Receivables
64.34M85.45M41.80M62.31M65.17M30.42M29.19M27.99M36.00M32.92M28.43M37.48M34.32M38.38M38.49M41.29M57.56M59.60M53.38M67.01M
Raw Materials
0.42M1.49M2.50M0.60M
Work In Process
0.20M0.55M0.26M3.92M
Inventory
33.00M27.33M25.61M24.77M22.33M13.29M14.01M26.91M25.39M23.97M21.34M18.67M16.74M14.11M14.61M15.49M11.90M9.13M13.27M10.26M
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
1.13M1.18M1.24M1.91M1.93M
Current Assets
432.08M464.75M276.07M243.78M220.43M263.60M328.19M276.71M253.99M237.43M368.91M312.26M309.39M331.56M309.32M352.94M753.92M832.27M865.41M1,457.12M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
18.70M13.19M24.58M30.95M33.42M12.48M11.74M11.38M16.18M15.61M15.13M14.97M15.09M15.13M3.62M3.63M3.47M
Long-Term Investments
375.00M375.00M375.00M375.00M375.00M3.00M375.00M375.00M33.10M36.73M36.50M10.74M10.91M10.91M10.91M10.91M106.72M121.45M87.77M114.48M
Goodwill
190.18M105.67M181.21M181.21M181.21M105.67M105.67M103.77M103.37M105.25M105.25M105.25M105.25M101.54M101.54M101.54M101.54M101.54M101.54M
Intangibles
562.37M376.69M539.71M528.36M517.02M342.45M333.92M325.38M314.84M299.61M291.42M283.16M274.90M266.65M258.39M250.13M233.53M225.44M217.34M209.24M
Goodwill & Intangibles
752.55M482.36M720.91M709.57M698.23M342.45M439.59M431.05M418.61M402.98M396.67M388.41M380.15M371.90M359.93M351.67M335.08M326.98M318.88M310.79M
Long-Term Deferred Tax
26.73M35.73M35.66M35.65M35.50M8.53M0.88M8.53M8.53M0.21M0.19M0.08M0.07M0.55M0.83M9.53M8.35M8.47M37.12M
Other Non-Current Assets
3.10M270.78M6.44M6.32M6.28M1.74M4.63M4.50M8.43M6.39M11.22M34.51M19.25M31.73M18.03M17.96M9.35M15.63M13.53M17.91M
Non-Current Assets
841.57M832.84M829.12M832.50M830.17M499.07M482.88M481.39M515.23M549.79M544.96M554.15M645.48M610.22M596.12M595.66M722.85M728.37M666.69M728.76M
Assets
1,273.66M1,297.59M1,105.18M1,076.29M1,050.61M762.67M811.08M758.11M769.23M787.22M913.87M866.40M954.87M941.77M905.43M948.60M1,476.77M1,560.64M1,532.11M2,185.88M
Liabilities
Current Liabilities
Accounts Payables
7.23M8.40M6.97M19.15M15.89M5.31M6.13M9.58M2.48M2.43M1.89M1.79M4.69M5.23M5.37M8.58M3.68M3.24M5.26M9.40M
Notes Payables
Payables
7.23M8.40M6.97M19.15M15.89M5.31M6.13M9.58M2.48M2.43M1.89M1.79M4.69M5.23M5.37M8.58M3.68M3.24M5.26M9.40M
Accumulated Expenses
12.24M17.58M15.88M14.55M19.34M15.68M14.98M7.29M10.63M12.47M12.43M12.17M15.60M27.91M23.54M17.46M24.08M31.45M31.84M31.87M
Other Accumulated Expenses
0.46M0.45M0.92M1.30M0.14M0.14M0.30M0.95M
Short term Debt
114.97M76.60M76.69M76.79M
Current Leases
2.23M1.41M1.90M2.55M2.39M0.71M0.04M0.41M0.00M0.01M0.02M1.29M0.02M0.02M1.12M
Current Taxes
5.80M3.78M9.70M11.39M1.20M1.14M2.09M2.11M1.20M1.80M0.30M1.28M1.24M1.89M3.22M
Current Deferred Revenue
12.01M0.65M10.50M10.58M9.55M0.35M0.26M1.22M1.23M1.20M1.15M1.28M0.10M0.11M
Total Current Liabilities
36.30M41.66M42.58M167.85M135.24M98.81M98.93M29.39M15.73M16.78M17.82M18.57M24.77M37.11M58.68M64.73M30.54M37.45M40.67M46.74M
Non-Current Liabilities
Non-Current Debt
445.49M446.19M446.90M1,126.59M
Convertible Debt
316.89M320.72M176.54M
Non-Current Deffered Revenue
9.27M7.43M5.54M0.04M1.44M3.06M2.70M2.51M2.25M
Preferred Stock Liabilities
Minority Interest
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
55.53M25.51M35.69M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
63.03M30.86M39.48M42.67M29.83M30.61M30.01M27.66M32.59M31.62M50.61M30.13M46.40M32.52M29.38M32.25M22.67M36.02M22.61M21.65M
Operating Leases
11.47M2.26M16.76M27.09M34.89M10.34M11.18M10.99M5.83M5.75M5.19M6.42M6.27M5.82M3.56M4.63M4.42M4.20M3.99M3.78M
Other Non-Current Liabilities
27.13M21.75M29.19M21.92M21.95M27.76M21.86M21.66M43.67M27.76M27.78M29.35M29.87M30.16M14.25M14.37M19.91M16.63M17.11M17.22M
Total Non-Current Liabilities
434.46M454.68M282.80M252.00M212.36M137.43M142.90M71.55M57.66M58.55M79.57M61.86M83.81M81.17M95.59M106.92M506.69M526.80M517.67M1,201.14M
Total Liabilities
461.59M476.43M311.99M273.92M234.31M165.18M164.76M93.21M101.33M86.30M107.35M91.21M113.69M111.33M109.84M121.29M526.60M543.42M534.78M1,218.36M
Shareholder's Equity
Total Debt
114.97M76.60M76.69M76.79M445.49M446.19M446.90M1,126.59M
Common Equity
812.07M821.16M793.19M802.37M816.30M597.49M646.32M664.89M667.90M700.91M806.52M775.20M841.18M830.44M795.59M827.31M950.17M1,017.21M997.32M967.52M
Liabilities and Shareholders Equity
1,273.66M1,297.59M1,105.18M1,076.29M1,050.61M762.67M811.08M758.11M769.23M787.22M913.87M866.40M954.87M941.77M905.43M948.60M1,476.77M1,560.64M1,532.11M2,185.88M
Treasury Shares
Retained Earnings
454.51M449.09M468.84M467.94M468.35M450.86M492.81M495.10M484.83M503.02M589.15M537.24M530.07M498.98M456.53M461.38M578.22M608.09M594.74M583.25M

Ligand Pharmaceuticals Balance Sheet API

Pull Ligand Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=LGND&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY